About
I am a Senior Research Officer at QIMR Berghofer. As a cardiovascular pharmacologist, my research has focussed on novel aspects of cell signalling and receptor biology, with publications in Cell, PNAS, Brit J Pharmacol.
After my BA/BSc (Hons) degrees (University of Melbourne) and PhD (University of Queensland), I led a large project on orphan GPCRs in Denmark, supported by consecutive Postdoctoral fellowships from Lundbeck Foundation and Danish Council for Independent Research. I returned to Australia in 2018 to Monash University to work on chemokine receptors and joined the Cardiac Bioengineering Group at QIMR Berghofer in late 2020.
Supported by a Bellberry-Viertel Fellowship, I am now combining my expertise in cardiovascular biology, cell signalling and drug discovery with the cardiac organoid platform to discover new cardiac fibrosis targets.
Research Skills
- Cell signalling and functional assays
- Phosphoproteomics
- Proteomics
- Human cardiac organoids
- Spatial proteomics
- Organ bath pharmacology
- Fluorescence and confocal microscopy
- RNA sequencing
Area of Interest
- Cardiac Fibrosis
- Heart failure
- Inflammation
- Pharmacology
- Drug discovery
- Cell signalling
- G protein-coupled receptors (GPCRs)
Professional Associations
- Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)
- International Society for Heart Research (ISHR)
- Australian Cardiovascular Alliance (ACvA)
- Queensland Cardiovascular Research Network (QCVRN)
- American Society for Pharmacology and Experimental Therapeutics (ASPET)
Funding
- Bellberry-Viertel Senior Medical Research Fellowship, “New cardiovascular therapeutics targeting fibrosis”, 2024-28
- NHMRC Ideas Grant, “Defining Chemotactic Signalling Networks to Identify New Anti-inflammatory Targets”, (CIB) 2022-25